{
    "2018-12-26": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players?",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "Giant Maw",
                        "Small-Cap Players"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Noteworthy ETF Outflows: MTUM, BA, DIS, LLY",
                "features": {
                    "keywords": [
                        "ETF Outflows",
                        "MTUM",
                        "BA",
                        "DIS",
                        "LLY"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "industrials",
                        "entertainment",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Bayer (BAYRY) Faces Generic Threat & Rising Competition",
                "features": {
                    "keywords": [
                        "Bayer",
                        "Generic Threat",
                        "Rising Competition"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}